ATE332928T1 - Triblockpolymere für arzneistoff- oder genzufuhr auf nanokugelbasis - Google Patents
Triblockpolymere für arzneistoff- oder genzufuhr auf nanokugelbasisInfo
- Publication number
- ATE332928T1 ATE332928T1 AT03808379T AT03808379T ATE332928T1 AT E332928 T1 ATE332928 T1 AT E332928T1 AT 03808379 T AT03808379 T AT 03808379T AT 03808379 T AT03808379 T AT 03808379T AT E332928 T1 ATE332928 T1 AT E332928T1
- Authority
- AT
- Austria
- Prior art keywords
- ananoball
- based medicine
- triblock polymers
- delivery
- genuine
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37804202P | 2002-05-15 | 2002-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE332928T1 true ATE332928T1 (de) | 2006-08-15 |
Family
ID=32230079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03808379T ATE332928T1 (de) | 2002-05-15 | 2003-05-15 | Triblockpolymere für arzneistoff- oder genzufuhr auf nanokugelbasis |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1504046B1 (de) |
AT (1) | ATE332928T1 (de) |
AU (1) | AU2003301690B2 (de) |
CA (1) | CA2486104C (de) |
DE (1) | DE60306769T2 (de) |
ES (1) | ES2270171T3 (de) |
WO (1) | WO2004039944A2 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060177416A1 (en) | 2003-10-14 | 2006-08-10 | Medivas, Llc | Polymer particle delivery compositions and methods of use |
US8591951B2 (en) * | 2002-05-15 | 2013-11-26 | Joachim B. Kohn | Tri-block copolymers for nanosphere-based drug delivery |
EP1848410A4 (de) * | 2005-02-17 | 2011-11-09 | Medivas Llc | Zusammensetzungen zur ausgabe von polymerteilchen und anwendungsverfahren dafür |
WO2007038246A2 (en) | 2005-09-22 | 2007-04-05 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US8445007B2 (en) | 2005-09-22 | 2013-05-21 | Medivas, Llc | Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use |
US20070134332A1 (en) * | 2005-11-21 | 2007-06-14 | Medivas, Llc | Polymer particles for delivery of macromolecules and methods of use |
CA2777234C (en) | 2009-10-11 | 2019-02-26 | Rutgers, The State University Of New Jersey | Biocompatible polymers for medical devices |
JP6045575B2 (ja) | 2011-06-23 | 2016-12-14 | ディーエスエム アイピー アセッツ ビー.ブイ. | 薬物送達のための新規な生分解性ポリエステルアミドコポリマー |
US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
US11472918B2 (en) | 2012-02-03 | 2022-10-18 | Rutgers, The State University Of New Jersey | Polymeric biomaterials derived from phenolic monomers and their medical uses |
EP3312155B1 (de) | 2012-02-03 | 2020-08-05 | Rutgers, The State University of New Jersey | Polymere biomaterialien aus phenolischen monomeren und deren medizinische verwendungen |
US10434071B2 (en) | 2014-12-18 | 2019-10-08 | Dsm Ip Assets, B.V. | Drug delivery system for delivery of acid sensitivity drugs |
US10774030B2 (en) | 2014-12-23 | 2020-09-15 | Rutgers, The State University Of New Jersey | Polymeric biomaterials derived from phenolic monomers and their medical uses |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5587507A (en) * | 1995-03-31 | 1996-12-24 | Rutgers, The State University | Synthesis of tyrosine derived diphenol monomers |
US6319492B1 (en) * | 1996-11-27 | 2001-11-20 | Rutgers, The State University | Copolymers of tyrosine-based polyarylates and poly(alkylene oxides) |
KR20010020536A (ko) * | 1997-06-27 | 2001-03-15 | 인테그라 라이프사이언시스 아이, 리미티드 | 이상 중합 방법 |
US6103255A (en) * | 1999-04-16 | 2000-08-15 | Rutgers, The State University | Porous polymer scaffolds for tissue engineering |
-
2003
- 2003-05-15 AT AT03808379T patent/ATE332928T1/de not_active IP Right Cessation
- 2003-05-15 AU AU2003301690A patent/AU2003301690B2/en not_active Ceased
- 2003-05-15 DE DE60306769T patent/DE60306769T2/de not_active Expired - Lifetime
- 2003-05-15 WO PCT/US2003/015600 patent/WO2004039944A2/en active IP Right Grant
- 2003-05-15 EP EP03808379A patent/EP1504046B1/de not_active Expired - Lifetime
- 2003-05-15 ES ES03808379T patent/ES2270171T3/es not_active Expired - Lifetime
- 2003-05-15 CA CA2486104A patent/CA2486104C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2486104C (en) | 2014-07-29 |
DE60306769T2 (de) | 2006-11-16 |
EP1504046A4 (de) | 2005-09-21 |
EP1504046A2 (de) | 2005-02-09 |
ES2270171T3 (es) | 2007-04-01 |
AU2003301690B2 (en) | 2009-08-13 |
AU2003301690A1 (en) | 2004-05-25 |
WO2004039944A2 (en) | 2004-05-13 |
CA2486104A1 (en) | 2004-05-13 |
WO2004039944A3 (en) | 2004-07-01 |
DE60306769D1 (de) | 2006-08-24 |
EP1504046B1 (de) | 2006-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE332928T1 (de) | Triblockpolymere für arzneistoff- oder genzufuhr auf nanokugelbasis | |
WO2007018544A3 (en) | Tri-block copolymers for nanosphere-based drug delivery | |
ATE317711T1 (de) | Elektropolymerisierbare monomere und polymerbeschichtungen auf implantierbaren geräten | |
MXPA02012601A (es) | Polimeros radicales cationicos o anfotericos autoadhesivos y su uso en cosmeticos. | |
ATE288956T1 (de) | Verwendung eines amphoteren polymeres zur behandlung ausgewählter harter oberflächen | |
TW200631604A (en) | Ophthalmic compositions comprising polyether substituted polymers | |
WO2001048190A3 (en) | Therapeutic uses of lna-modified oligonucleotides | |
WO2004009664A3 (en) | Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from | |
DE602004022834D1 (de) | Biologisch absorbierbare überzüge für implantierbare vorrichtungen | |
WO2007124132A2 (en) | Polymeric compositions and methods of making and using thereof | |
CA2308721A1 (en) | Radio-opaque polymer biomaterials | |
DE60028415D1 (de) | Methode und zusammensetzungen für verbesserte abgabevorrichtungen | |
WO2008082738A3 (en) | N-substituted monomers and polymers | |
EP1196149A4 (de) | IN ORGANISCHEN LÖSEMITTELN LÖSLICHE BIOLOGISCH ABBAUBARE POLY (ALKYLENOXID)- POLY (p-DIOXANON) BLOCKCOPOLYMERE SOWIE DIESE ENTHALTENDE ZUSAMMENSETZUNG ZUR ARZNEISTOFFVERABREICHUNG | |
WO2002039948A3 (en) | Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants | |
ATE460437T1 (de) | Polymere von fluormonomeren und hydrophilen monomeren | |
GB9814609D0 (en) | Polymers | |
BR0214136A (pt) | Polìmeros de enxerto, processo para a preparação e uso dos mesmos | |
DE60334388D1 (de) | Blockcopolymer-mizellenzusammensetzung mit verbesserter arzneimittelbeladungskapazität und verzögerter freisetzung | |
GB2451599A (en) | Nanostructures suitable for delivery of agents | |
DE602004025210D1 (de) | Azlacton-photoiniferter für die radikalische polymerisation | |
WO2006044795A3 (en) | Electrochemically degradable polymers | |
IL177777A0 (en) | Polymer particles containing active agents | |
TW200613012A (en) | Sustained-release composition, process for producing the same and use of the same | |
AUPR412801A0 (en) | Agent for the prevention and treatment of sexually transmitted disease s - I |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |